RxDoctor Payments DataLook up a doctor →

Kunal Agarwal, MD

Sleep Medicine · Sarasota, FLNPI 1932497773

Payments from drug & device makers

$153,311in general payments, 2019–2025

Across 686 payments — averaging $223.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Idorsia Pharmaceuticals US Inc$35K
  • Inspire Medical Systems, Inc.$26K
  • Axsome Therapeutics, Inc.$26K
  • ZOLL Respicardia, Inc.$25K
  • Jazz Pharmaceuticals Inc.$19K
  • Eisai Inc.$10K
  • plus $12K from 53 others

What the payments were for

  • Consulting fees$17,53511%
  • Speaking & faculty fees$104,88068%
  • Travel & lodging$9,5876%
  • Food & beverage$21,13214%
  • Education$1770%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Idorsia Pharmaceuticals US Inc60$34,701
Inspire Medical Systems, Inc.58$26,495
Axsome Therapeutics, Inc.54$25,574
ZOLL Respicardia, Inc.27$25,316
Jazz Pharmaceuticals Inc.121$19,379
Eisai Inc.26$9,604
Harmony Biosciences LLC100$2,511
Fisher & Paykel Healthcare Inc4$1,812
Novo Nordisk38$1,729
Takeda Pharmaceuticals U.S.A., Inc.14$1,209
AstraZeneca12$444
Avadel CNS Pharmaceuticals, LLC10$422
Pfizer26$415
Amgen11$407
Lilly USA, LLC14$368
Biohaven Pharmaceuticals, Inc.8$285
Sunovion Pharmaceuticals Inc.13$218
Vanda Pharmaceuticals Inc.7$211
AbbVie(2 entities)7$211
Itamar Medical Inc3$193
Abbott6$176
Merit Medical Systems Inc1$161
GSK2$140
Mylan Specialty L.p.1$125
Resmed Corp6$115
Irhythm Technologies, Inc.4$111
Azurity Pharmaceuticals, Inc.4$79
Arbor Pharmaceuticals, Inc.4$61
Merck3$59
Boehringer Ingelheim3$54
Otsuka Pharmaceutical Development & Commercialization, Inc.2$52
Mallinckrodt Enterprises LLC2$52
Amarin Pharma, Inc.3$47
Exact Sciences2$45
Philips North America LLC2$39
Sanofi2$37
3b Medical, Inc.2$34
Ferring Pharmaceuticals Inc.1$32
Boston Scientific1$30
Regeneron Healthcare Solutions, Inc.1$29
Livanova USA, Inc.2$28
Johnson & Johnson2$25
Tactile Systems Technology Inc1$21
Corcept Therapeutics1$20
Daiichi Sankyo Inc.1$19
Avanir Pharmaceuticals, Inc.1$19
Sumitomo Pharma America, Inc.1$18
UCB, Inc.1$18
Phathom Pharmaceuticals, Inc.1$18
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$17
Novartis1$16
Insmed, Inc.1$15
Astellas Pharma US Inc1$15
Baxter Healthcare1$15
Shire North American Group Inc1$14
Dermira, Inc.1$13
Circassia Inc.1$13
Gilead1$11
Supernus Pharmaceuticals, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$153,311 in reported general payments places this provider in the 90th percentile of 77 sleep medicine providers in Florida.

See all sleep medicine providers in Florida

Medicare billing

Part B allowed, 2024
$790,414
Medicare patients
1,495
Services billed
9,461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
WakixPitolisant Hcl18$254,204
QuviviqDaridorexant Hcl22$11,941
DayvigoLemborexant11$5,546
Ropinirole Hcl39$1,172
Gabapentin67$964
Buprenorphine Hcl34$923
Eszopiclone51$724
Clonazepam211$542
Methadone Hcl43$503
Trazodone Hcl57$473
Modafinil15$396
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine11$286
Fluticasone Propionate14$249
Hydroxyzine Hcl16$227
Methylphenidate Hcl11$224

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Harmony Biosciences LLCWakix$2,511$254,20418 claims
Idorsia Pharmaceuticals US IncQuviviq$34,701$11,94122 claims
Eisai Inc.Dayvigo$9,604$5,54611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 77 sleep medicine providers in Florida.

Other sleep medicine in Sarasota

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →